Jianfeng Group said on an interactive platform on May 17 that Jianfeng Pharmaceutical's Jinxi production base's solid preparation project with an annual output of 2 billion tablets has completed on-site FDA inspection and has not yet received an EIR on-site inspection report.
尖峰集团：尖峰药业金西生产基地年产20亿片固体制剂项目已完成FDA现场检查
Jianfeng Group: Jianfeng Pharmaceutical's Jinxi production base solid formulation project with an annual output of 2 billion tablets has completed FDA on-site inspection
The translation is provided by third-party software.
The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.